Abstract
Mycobacterium Tuberculosis HSP16.3 is a major antigen maximally expressed during the stationary phase. Previous studies showed that HSP16.3 can function as a molecular chaperone in vitro. Here, crystallization trails of HSP 16.3 were reported. A kind of crystal can be diffracted to 2.8 A resolution at the ”Photon Factory“, a synchrotron light source in Japan. The crystal displayed the space group R3 with unit cell parameters a=b=110 A , c=152 A and gamma=120 degree. Assuming the presence of 9 HSP16.3 molecules in an asymmetric unit, it gives a Vm= 0.73 A 3 / Da. and solvent content of 35percent by volume.
Keywords: MYCOBACTERIUM TUBERCULOSIS HSP16.3, IPTG isopropyl ß-D-thiogalacto-pyranoside, MPD 2-Methyl-2,4-Pentanediol, sHSP small heat shock protein, MAD Multiwavelength Anomalous Dispersion, molecular chaperone activity
Protein & Peptide Letters
Title: Preliminary X-Ray Crystallographic Studies Of The Mycobacterium Tuberculosis Hsp16.3 Molecular Chaperone
Volume: 8 Issue: 6
Author(s): Y. Chen, J. An, Y. Ding, H. Dai, Q. Mao, L. Feng, B. Liu, Y. Chang, F. Chen, H. He, H. Tang, Z. Chang and Z. Rao
Affiliation:
Keywords: MYCOBACTERIUM TUBERCULOSIS HSP16.3, IPTG isopropyl ß-D-thiogalacto-pyranoside, MPD 2-Methyl-2,4-Pentanediol, sHSP small heat shock protein, MAD Multiwavelength Anomalous Dispersion, molecular chaperone activity
Abstract: Mycobacterium Tuberculosis HSP16.3 is a major antigen maximally expressed during the stationary phase. Previous studies showed that HSP16.3 can function as a molecular chaperone in vitro. Here, crystallization trails of HSP 16.3 were reported. A kind of crystal can be diffracted to 2.8 A resolution at the ”Photon Factory“, a synchrotron light source in Japan. The crystal displayed the space group R3 with unit cell parameters a=b=110 A , c=152 A and gamma=120 degree. Assuming the presence of 9 HSP16.3 molecules in an asymmetric unit, it gives a Vm= 0.73 A 3 / Da. and solvent content of 35percent by volume.
Export Options
About this article
Cite this article as:
Chen Y., An J., Ding Y., Dai H., Mao Q., Feng L., Liu B., Chang Y., Chen F., He H., Tang H., Chang Z. and Rao Z., Preliminary X-Ray Crystallographic Studies Of The Mycobacterium Tuberculosis Hsp16.3 Molecular Chaperone, Protein & Peptide Letters 2001; 8 (6) . https://dx.doi.org/10.2174/0929866013409111
DOI https://dx.doi.org/10.2174/0929866013409111 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integrase Strand Transfer Inhibitors and the Emergence of Immune Reconstitution Inflammatory Syndrome (IRIS)
Current HIV Research Synthesis and Antimycobacterial Evaluation of N-(E)-heteroaromaticpyrazine-2-carbohydrazide Derivatives
Medicinal Chemistry Prediction of Translation Initiation Site in Bacterial and Archaeal Genomes
Current Bioinformatics A Randomized, Single Centered, Parallel and Open Labelled Interventional Study on Effectiveness of Clinical Pharmacists on Adverse Event Following Immunization (AEFI) in Pediatric Population
Current Drug Safety Application, Reactivity and Synthesis of Isoxazole Derivatives
Mini-Reviews in Organic Chemistry Divergent Behavior of the Reactions Between 1,2-Diaza-1,3-dienes and 2,5- Dioxoimidazolidin-4-ylidene-succinates
Current Organic Synthesis p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Th2 Cytokines in Susceptibility to Tuberculosis
Current Molecular Medicine Treatment of Tuberculosis: Use of Active Pharmaceuticals
Recent Patents on Anti-Infective Drug Discovery Design, Synthesis and In vitro Biological Activity of Some New 1,3- thiazolidine-4-one Derivatives as Chemotherapeutic Agents using Virtual Screening Strategies
Current Computer-Aided Drug Design Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective
Current Medicinal Chemistry miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
Current Genomics Timely Identification of Disease by Parallel Real-time Automated Processing of Huge Medical Databases of Images Distributed Geographically, through Knowledge Sharing
Current Bioinformatics Asthma in Childhood – Making the Diagnosis
Current Pediatric Reviews Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis
Current HIV Research Enhanced Killing of Intracellular Pathogenic Bacteria by Phenothiazines and the Role of K+ Efflux Pumps of the Bacterium and the Killing Macrophage
Anti-Infective Agents in Medicinal Chemistry Pulmonary Vaccine Delivery Systems: A Novel Approach for Immunization
Current Drug Therapy Anti-Bacterial
Current Bioactive Compounds Terpenoids form the Sea: Chemical Diversity and Bioactivity
Current Organic Chemistry